100%
1-year holding
of 1 windows beat the index
Avg / yr+2.7%
6.7
Nyra score
Independently scored
1-yr track record · since Jan 2025ValueAUM ₹49 CrSEBI-registered PMS
3Y CAGR
—
annualised
5Y CAGR
—
annualised
Since inception
2.7%
CAGR · net of fees
₹1 Cr became
₹1.03 Cr
index ₹1.02 Cr
AUM
₹49 Cr
strategy size
Minimum
₹50 L
SEBI minimum
Snapshot
What this strategy is
Bottoms up approach that prioritizes research, dedicating the majority of its time and resources to identifying and thoroughly analysing companies across various sector in India following.
Performance · what ₹1 crore would have become
₹1.03 Cr
+3% · 1.0× your money
- This strategy₹1.03 Cr
- S&P BSE 500 Total Return Index₹1.02 Cr
₹1 Cr invested at inception (Jan 2025)1.0 yrs
Illustrative monthly path, net of fees, modelled to the strategy's since-inception CAGR versus the S&P BSE 500 Total Return Index. Not the actual NAV series; past performance is not indicative of future returns.
Returns
Trailing returns vs benchmark
Absolute for windows under a year, annualised (CAGR) beyond. Alpha is the strategy minus its benchmark.
1M
3M
6M
1Y
3Y
5Y
SI
This strategy25.4%
14.6%
-5.5%
9.5%
—
—
2.7%
S&P BSE 500 Total Return Index
10.4%
-1.7%
-4.3%
3.6%
—
—
1.8%
Alpha
+15%
+16.3%
-1.2%
+5.9%
—
—
+0.9%
Reliability
How often it has beaten the index
Across every rolling holding period in the modelled history — the longer you hold, the more the odds have favoured the strategy.
Computed on an illustrative monthly path modelled to the since-inception CAGR — not the actual NAV series.
Risk
The quality of those returns
Returns mean little without the ride that earned them.
−12.5%
Max drawdown
2.7%
Worst 1-yr window
17.2%
Volatility (ann.)
10.70
Sharpe ratio
A Sharpe of 10.70 means it earned a healthy return for each unit of risk taken. Size the position so a drawdown of that order is one you can sit through.
Portfolio
Under the hood — where the money sits
Spread across the market-cap curve.
Market-cap mix
- Small100%
Concentration
Holdings—
Cash / debt buffer—
Top holdings and the sector book stream from the live feed — ask Nyra for the current portfolio.
Manager
Who runs the money
A strategy is only as good as the hand on the wheel.
Fund manager
Investment team
NMR GROWTH · 1-yr strategy tenure · ₹49 Cr managed
Investment philosophy
NMR GROWTH's Small Cap approach leans on valuation discipline — buying solid businesses for less than they are worth and waiting for the gap to close. It is benchmarked to the S&P BSE 500 Total Return Index but invests with conviction rather than hugging the index.
Conviction over the index
A focused book of roughly 30–40 holdings means the highest-conviction ideas actually move the portfolio.
Through the cycle
A 1-year track record across rallies and drawdowns — positioning shifts with the cycle rather than chasing the last quarter.
Risk first
Drawdowns are managed deliberately; the worst peak-to-trough on record is kept in check.
Nyra's read
A small cap strategy with a mixed but improving profile.
Nyra scores NMR GROWTH STRATEGY 6.7/10, on a since-inception CAGR near 2.7%. Drawdowns have stayed contained — size the position so that ride is one you can hold.
Best suited to
Investors with a 5-year-plus horizon who want active Small Cap exposure and can sit through equity drawdowns.
Mind if
A double-digit drawdown would test your nerve, or you need ₹50 L+ to commit at the SEBI minimum.
Pairs well with
A steadier core (large-cap or hybrid) so this can play the higher-conviction satellite in your overall allocation.
Facts & fees
The fine print, in plain sight
- Inception
- Jan 2025
- Track record
- 1 years
- Category
- Equity: Small Cap
- Style
- Value
- Benchmark
- S&P BSE 500 Total Return Index
- Holdings
- —
- Fixed fee
- —
- Performance fee
- Performance-linked
- Minimum investment
- ₹50 L
- Lock-in / exit
- Exit Load: 1 Year: NA, 2 Year:NA, 3 Year: NA
- Reporting
- Monthly + live login
- Regulator
- SEBI-registered PMS
PMS Sahi Hai is a SEBI-registered platform. Figures are sourced from the strategy's disclosures and the live feed; the growth chart, rolling-window and risk figures are modelled to the disclosed since-inception CAGR (illustrative, not the actual NAV series). Returns are net of fees where stated. Investments in PMS, AIF and GIFT City strategies are subject to market risk — past performance is not indicative of future results. This page is information, not investment advice.
What investors say
“I held two PMS for four years and couldn't tell you why. One 15-minute review showed me the overlap, the real post-tax number, and one fund worth replacing. Nobody had ever shown me that math.”
Rajesh K.HNI · Mumbai · ₹3.2 Cr · 2 PMS reviewedComposite client stories — names changed, numbers preserved.
FAQ
NMR GROWTH STRATEGY — common questions
What is NMR GROWTH STRATEGY?
NMR GROWTH STRATEGY is a Small Cap PMS strategy from NMR GROWTH. It follows a Value style, is benchmarked to the S&P BSE 500 Total Return Index, and carries a Nyra score of 6.7/10.
Who should consider NMR GROWTH STRATEGY?
It suits investors with a five-year-plus horizon who want active Small Cap exposure and can stay invested through market drawdowns. The SEBI minimum is ₹50 L.
What returns has it delivered?
Since inception (Jan 2025) it has compounded at roughly 2.7% a year. Returns are net of fees; past performance is not a guarantee of future results.
What are the fees and lock-in?
—, with a performance fee of Performance-linked. Exit / lock-in terms: Exit Load: 1 Year: NA, 2 Year:NA, 3 Year: NA.
How risky is it?
Like all market-linked products it can fall in value; the worst drawdown on record is disclosed in the factsheet. NMR GROWTH is SEBI-registered and reports monthly. This page is information, not investment advice.
